Novel molecules to target the cytoskeleton

August 1, 2013
Novel molecules to target the cytoskeleton
Growth of lamellar networks of actin filaments after the addition of the new compounds (compare the cell contours on the left and right). Credit: ISIS/IGBMC

The dysfunction of the cytoskeleton, a constituent element of the cell, is often associated with pathologies such as the onset of metastases. For this reason, it is a target of interest in numerous therapies. Teams from CNRS, the Université de Strasbourg and Inserm, led by Daniel Riveline, Jean-Marie Lehn and Marie-France Carlier, have synthesized molecules capable of causing rapid growth of actin networks, one of the components of the cytoskeleton. This is a breakthrough because, until now, only molecules that stabilize or destroy the cytoskeleton of actin have been available. These compounds with novel properties, whose action has been elucidated both in vitro and in vivo, provide a new tool in pharmacology. This work was published in the journal Nature Communications on 29 July 2013.

The is mainly composed of actin filaments and . Made of polymers in dynamic assembly and constantly constructing and deconstructing itself, it affects numerous such as intracellular movement, division and transport. It is involved in key steps of embryogenesis and other processes essential to life. Consequently, its malfunctioning can lead to serious pathologies. For example, the onset of certain is revealed by an increased activity of the cytoskeleton. Identifying new molecules that target the cytoskeleton thus represents a major challenge.

Until now, the molecules known and used in pharmacology had the effect of stabilizing or destroying the cytoskeleton of actin. Actin allows vital actions to be performed by assembling and disassembling itself spontaneously, continually and rapidly in the form of filaments that organize themselves and form networks of parallel bundles or intertwined meshes (known as lamellar networks). Derived from supramolecular chemistry, the new compounds synthesized by the researchers have original properties: within several minutes, they bring about the growth of lamellar networks of . This is the first time that a pharmacological tool induces growth of the actin network - something that living organisms do all the time. In this way, the researchers have shown that the action of these compounds is specific in vivo (on cells). In addition, they have identified the growth mechanism of the actin network by comparative in vivo and in vitro studies in order to ensure the validity of the process.

For cellular or molecular biology, this tool proposes a new mode of possible action on the cytoskeleton and thus opens new research perspectives for deciphering the living world. This finding could lead to the development of new compounds, derived from the same chemistry, and potential candidates for new therapies targeting the cytoskeleton.

Explore further: Tumor suppressor APC could stop cancer through its effect on actin cytoskeleton

More information: Nedeva, I. et al. Nature Communications, 29 July 2013. DOI: 10.1038/ncomms3165

Related Stories

The determining factors of cell shape examined

October 4, 2012

A European team is investigating the role of the bacterial cell wall and the cytoskeleton in mediating cell shape. Results are expected to have broader implications for cell biology.

Scientists study transient degradation of an actin regulator

February 13, 2013

Scientists at the Center for Molecular Biology of Heidelberg University have gained new insight into the process of mitosis in mammalian cells. Researchers under the direction of Prof. Dr. Frauke Melchior, in collaboration ...

Recommended for you

Reprogramming the oocyte

August 26, 2015

(Phys.org)—Among other things, the egg is optimized to process the sperm genome. The cytoplasmic factors that make this possible also give the egg the ability to reprogram the nuclei from other kinds of cells if these nuclei ...

Research advances on transplant ward pathogen

August 28, 2015

The fungus Cryptococcus causes meningitis, a brain disease that kills about 1 million people each year—mainly those with impaired immune systems due to AIDS, cancer treatment or an organ transplant. It's difficult to treat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.